Skip to content

Pharming Group N.V.

PHAR

CIK 0001828316

← back to feed
Revenue (TTM)
—
FY Dec 2025
Net Income (TTM)
€2.54M
+121.4% YoY FY Dec 2025
EPS Diluted (TTM)
€0.00
+122.2% YoY FY Dec 2025
Gross Margin
—
FY Dec 2025
Operating Margin
—
FY Dec 2025
Net Margin
—
FY Dec 2025
Free Cash Flow (TTM)
—
FY Dec 2025
Cash
€145.31M
FY Dec 2025
Total Debt
—
FY Dec 2025
Shares Outstanding
701.68M sh
FY Dec 2025

Revenue & Net Income

EPS (Diluted)

Cash Flow

Revenue Growth (YoY)

No data available for this metric.

Balance Sheet

Cash vs Debt

Recent filings